[ Back to EurekAlert! ] Public release date: 10-Dec-2012
[ | E-mail Share Share ]

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer

Springer launches new journal with the Italian Association of Nuclear Medicine and Molecular Imaging

Clinical and Translational Imaging will be devoted to comprehensive review articles on research and clinical applications in the field

Springer will launch a new journal Clinical and Translational Imaging: Reviews in Nuclear Medicine and Molecular Imaging. The bi-monthly publication will be the official journal of the Italian Association of Nuclear Medicine and Molecular Imaging (AIMN) as of 2013.

Prof. Giovanni Lucignani, Editor-in-Chief of the new journal and President of AIMN, said, "AIMN has long been committed to consistently raising the standard and impact of its scientific publications and we now feel that the time has come to launch our own official journal. We will be embarking on this exciting project strengthened by the support and experience of a prestigious partner, Springer, whose vision and priorities are very much in line with our own."

Targeting nuclear medicine practitioners and other professionals involved in molecular imaging and therapy, this international peer-reviewed journal will publish timely and updated reviews, collected in monothematic issues, on clinical practice and translational research. It will also present clinical applications of approved and experimental radiopharmaceuticals for diagnostic and therapeutic purposes. Advanced preclinical evidence in the fields of physics, dosimetry, radiation biology and radiopharmacy, with relevance to applications in humans, will also be included in the journal. Papers will be selected by an editorial board made up of internationally renowned experts.

Carlotta d'Imporzano, Executive Editor, Medical Journals at Springer, said, "The journal will be made available through Springer's online platform link.springer.com and will therefore enjoy international visibility and global exposure. We are honored to have been chosen as the publisher of this new journal, and are looking forward to supporting AIMN in its mission."

###

AIMN promotes the scientific development and application of nuclear medicine and molecular imaging. It is a key point of reference, both scientific and professional, for medical doctors and other specialists in this field.

Springer Science+Business Media is a leading global scientific publisher, providing researchers in academia, scientific institutions and corporate R&D departments with quality content via innovative information products and services. Springer is also a trusted local-language publisher in Europe especially in Germany and the Netherlands primarily for physicians and professionals working in the automotive, transport and healthcare sectors. Roughly 2,000 journals and more than 7,000 new books are published by Springer each year, and the group is home to the world's largest STM eBook collection, as well as the most comprehensive portfolio of open access journals. Springer employs nearly 7,000 individuals across the globe and in 2011 generated sales of approximately EUR 875 million.

Clinical and Translation Imaging
ISSN 2281-5872 (print version)



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.